Abiopharma

(30% Negative) CULLINAN THERAPEUTICS, INC. (CGEM) Reports Q2 2026 Financial Results

(99% Positive) CREATIVE MEDIA&COMMUNITY TRUST CORPORATION DUAL LISTED (U) Reports Q2 2026 Financial Results

(30% Negative) ARROW ELECTRONICS, INC. (ARW) Reports Q2 2026 Financial Results

New Form DFAN14A - BlackRock ESG Capital Allocation Term Trust <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0000902664-26-002301 <b>Size:</b> 6 MB

(30% Negative) APYX MEDICAL CORP (APYX) Reports Q2 2026 Financial Results

Amazon Pharmacy Expands Access to New Ozempic® Pill via Same-Day Delivery, Kiosks

(30% Negative) AMYLYX PHARMACEUTICALS, INC. (AMLX) Reports Q2 2026 Financial Results

New Form SCHEDULE 13G/A - Samsara Inc. <b>Filed:</b> 2026-05-07 <b>AccNo:</b> 0001088875-26-000034 <b>Size:</b> 7 KB

Insmed Reports First-Quarter 2026 Financial Results and Provides Business Update

(30% Negative) SHAKE SHACK INC. (SHAK) Reports Q2 2026 Financial Results

(30% Negative) N-ABLE, INC. (NABL) Reports Q2 2026 Financial Results

(30% Negative) BKV CORP (BKV) Reports Q2 2026 Financial Results

(70% Positive) SHIFT4 PAYMENTS, INC. (FOUR) Reports Q2 2026 Financial Results

(99% Positive) MIDDLEBY CORP (MIDD) Reports Q2 2026 Financial Results

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Change in Directors Interest